Tumor antidote (oncoclasine) for the cure of tumors, and process for its extraction
    4.
    发明公开
    Tumor antidote (oncoclasine) for the cure of tumors, and process for its extraction 失效
    用于治疗肿瘤的肿瘤抗原(ONCOCLASINE)及其提取方法

    公开(公告)号:EP0027429A3

    公开(公告)日:1982-05-12

    申请号:EP80810238

    申请日:1980-07-28

    CPC分类号: A61K35/24 A61K35/14 A61K35/22

    摘要: The inventor proceeds from the observation that goats never have the phenomena of tumors and cancerous growths. After long study and research, excrements (feces and urine) were extracted from male and female goats in two varieties of tumor antidote which are designated respectively as "M" and "F", the first used for the cure of carcinomas and all tumors of the epithelial tissue, except for prostate carcinomas, the second for the cure of sarcomas and tumors of the connective tissue, including leukemia and prostate carcinomas. The extraction process consists of soaking the feces and urine of the same animal, in approximately 1/3 part twice-distilled water, for approximately 48 hours, and filtering the entirety first in normal filters, then in sterilized filters, preferably of the "millipore" type.

    FLUID FROM SKIN AND OMENTUM FOR MEDICAL USE
    5.
    发明授权
    FLUID FROM SKIN AND OMENTUM FOR MEDICAL USE 有权
    用于医疗用途的皮肤和药物流体

    公开(公告)号:EP2467149B1

    公开(公告)日:2018-04-04

    申请号:EP10751726.0

    申请日:2010-08-13

    申请人: Singh, Ashok K.

    发明人: Singh, Ashok K.

    CPC分类号: A61K35/24

    摘要: Apparatus and process to create, expand, and localize the population of stem cells in adult tissues by placing a foreign body either in omentum or in the subcutaneous tissue. The apparatus 1) traps the granulation fluid, cells a fluid rich in a myriad of growth factors, 2) mobilizes and concentrates free-floating stem cells in the granulation fluid, and 3) stimulates the growth of a new tissue around the apparatus, which provides another source of stem cells. Stem cells obtained by this process can be used as freshly isolated or after culturing, which can be used for wound healing, treating diseases, and regenerating organs in animals and humans. The granulation fluid could substitute the stem cells in many of their applications and offers the convenience of an injectable medicine for treating animal and human diseases.

    Therapeutic use of an extract from the leaves of Nerium oleander
    6.
    发明公开
    Therapeutic use of an extract from the leaves of Nerium oleander 审中-公开
    维他命Een Nerium-oleanderBlätterextrakts

    公开(公告)号:EP1803461A1

    公开(公告)日:2007-07-04

    申请号:EP05028529.5

    申请日:2005-12-27

    IPC分类号: A61K36/24

    CPC分类号: A61K35/24

    摘要: The present invention relates to the use of a sterile non-toxic pyrogen-free extract from the leaves of Nerium oleander in the manufacture of a medicament for the treatment of cancers of bladder, brain, head and neck, kidney, liver, ovary, pancreas, pleuramesothelioma, testicle, uterus, and vagina as well as Hodgkin's lymphomas, melanomas and sarcomas, and as a supplementary medication to cancer chemo-, hormon and radiotherapy to restore and/or ameliorate the immune system of the patient and to decrease side effects of chemotherapeutics and radiotherapy. Furthermore, it will be used in viral, infectious and inflammatory diseases such as hepatitis B, hepatitis C, influenza, and immune deficient disorders like HIV/AIDS.

    摘要翻译: 本发明涉及使用来自夹竹桃的叶子的无菌无毒无热原提取物在制备用于治疗膀胱,脑,头和颈,肾,肝,卵巢,胰腺癌症的药物中的用途 ,胸膜炎,睾丸,子宫和阴道以及霍奇金淋巴瘤,黑素瘤和肉瘤,以及作为癌症化学,激素和放射治疗的补充药物,以恢复和/或改善患者的免疫系统并减少副作用 化学治疗和放疗。 此外,它将用于病毒,感染和炎症疾病,如乙型肝炎,丙型肝炎,流行性感冒和免疫缺陷病例如艾滋病毒/艾滋病。

    COMPOSITIONS FOR FECAL FLORAL TRANSPLANTATION AND METHODS FOR MAKING AND USING THEM
    9.
    发明公开
    COMPOSITIONS FOR FECAL FLORAL TRANSPLANTATION AND METHODS FOR MAKING AND USING THEM 审中-公开
    用于直接移植的组合物及其制备和使用方法

    公开(公告)号:EP3311825A1

    公开(公告)日:2018-04-25

    申请号:EP17203052.0

    申请日:2011-08-04

    摘要: In alternative embodiments, the invention provides compositions, e.g., formulations, used for gastric, gastrointestinal and/or colonic treatments or lavage, e.g., orthostatic lavage, e.g., for inducing the purgation (e.g., cleansing) of a gastrointestinal (GI) tract, including a colon; and methods for making and using them. In alternative embodiments, compositions and methods of the invention are used for the stabilization, amelioration, treatment and/or prevention of constipation, for the treatment of abdominal pain, particularly non-specific abdominal pain, and diarrhea, including diarrhea caused by a drug side effect, a psychological condition, a disease or a condition such as Crohn's Disease, a poison, a toxin or an infection, e.g., a toxin-mediated traveler's diarrhea, or C.difficile or the pseudo-membranous colitis associated with this infection. In alternative embodiments, the invention provides pharmaceuticals and products (articles) of manufacture for delivering these compositions and formulations to an individual, e.g., a human or an animal. The invention also provides devices for delivering a fecal material to a patient.

    摘要翻译: 在可选的实施方案中,本发明提供用于胃肠道和/或肠道治疗或灌洗的组合物,例如制剂,例如用于诱导胃肠(GI)道的净化(例如清洁),例如直立性灌洗, 包括冒号; 以及制作和使用它们的方法。 在可选的实施方案中,本发明的组合物和方法用于稳定,改善,治疗和/或预防便秘,用于治疗腹痛,特别是非特异性腹痛和腹泻,包括由药物侧引起的腹泻 效应,心理状况,疾病或病症如克罗恩氏病,毒物,毒素或感染(例如毒素介导的旅行者腹泻)或C.difficile或与该感染相关的假膜性结肠炎。 在可选的实施方案中,本发明提供了用于将这些组合物和制剂递送给个体例如人或动物的药物和产品(制品)。 本发明还提供了用于将粪便物质递送给患者的装置。

    METHODS AND COMPOSITIONS FOR INTESTINAL MICROENVIRONMENT TRANSFER
    10.
    发明公开
    METHODS AND COMPOSITIONS FOR INTESTINAL MICROENVIRONMENT TRANSFER 审中-公开
    方法和组合物肠道微生态区域传送

    公开(公告)号:EP3107553A1

    公开(公告)日:2016-12-28

    申请号:EP15705603.7

    申请日:2015-02-18

    IPC分类号: A61K35/24 A61P1/00

    CPC分类号: A61K35/24 Y02A50/475

    摘要: The present invention relates to novel methods and compositions for positively influencing or normalising the human intestinal microbiota. The invented technique is termed intestinal microenvironment transfer (IMEnT) and comprises the preparation of a mixture of metabolites, nutrients and mediators produced by both the intestinal microbiota and the body cells of a healthy animal, especiallymammal, andparticularlypig or human, donor and transfer of this mixture (the IMEnT preparation)to a recipient of the same or another species suffering from intestinal dysbiosis in order to revitalise and/or normalise the recipient's endogenous microbiota. In particular, the present invention relates to pharmaceutical compositions and formulations as well as dietary supplements for specific and/or selective delivery of the IMEnT preparations into the small intestine and/or the large intestine.